These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11905586)
61. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors]. Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436 [TBL] [Abstract][Full Text] [Related]
62. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904 [TBL] [Abstract][Full Text] [Related]
63. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease. Hopewell JC; Seedorf U; Farrall M; Parish S; Kyriakou T; Goel A; Hamsten A; Collins R; Watkins H; Clarke R; J Intern Med; 2014 Sep; 276(3):260-8. PubMed ID: 24372611 [TBL] [Abstract][Full Text] [Related]
64. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation. Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832 [TBL] [Abstract][Full Text] [Related]
66. Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women. Derosa G; Fogari R; Piccinni MN; Peros E; Bertone G; Ciccarelli L; Tinelli C; Geroldi D; Pannacciulli N; De Pergola G Obes Res; 2004 Aug; 12(8):1322-6. PubMed ID: 15340115 [TBL] [Abstract][Full Text] [Related]
67. Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly. Räihä I; Marniemi J; Puukka P; Toikka T; Ehnholm C; Sourander L Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1224-32. PubMed ID: 9261250 [TBL] [Abstract][Full Text] [Related]
68. Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects. Tasaki H; Nakashima Y; Nandate H; Yashiro A; Kawashima T; Kuroiwa A Am J Cardiol; 1989 Jun; 63(20):1441-5. PubMed ID: 2729130 [TBL] [Abstract][Full Text] [Related]
69. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients. Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034 [TBL] [Abstract][Full Text] [Related]
70. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease. Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116 [TBL] [Abstract][Full Text] [Related]
71. [Dynamics of blood lipoprotein and apolipoprotein spectra in patients with unstable angina syndrome during a 1-year follow-up]. Ruda MIa; Perova NV; Noeva EA; Karpov IuA; Metel'skaia VA Kardiologiia; 1989 Nov; 29(11):38-43. PubMed ID: 2615176 [TBL] [Abstract][Full Text] [Related]
72. Plasma lipid, apolipoprotein and Lp(a) levels in elderly normolipidemic women: relationships with coronary heart disease and longevity. Barbagallo CM; Averna MR; Fradà G; Chessari S; Mangiacavallo G; Notarbartolo A Gerontology; 1995; 41(5):260-6. PubMed ID: 8537009 [TBL] [Abstract][Full Text] [Related]
73. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a). Muls E; Kempen K; Vansant G; Cobbaert C; Saris W Int J Obes Relat Metab Disord; 1993 Dec; 17(12):711-6. PubMed ID: 8118476 [TBL] [Abstract][Full Text] [Related]
74. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913 [TBL] [Abstract][Full Text] [Related]
75. Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults. Beheshtian A; Shitole SG; Segal AZ; Leifer D; Tracy RP; Rader DJ; Devereux RB; Kizer JR Atherosclerosis; 2016 Oct; 253():47-53. PubMed ID: 27575936 [TBL] [Abstract][Full Text] [Related]
79. Lipoprotein(a) and its position among other risk factors of atherosclerosis. Zlatohlávek L; Zídková K; Vrablík M; Haas T; Prusíková M; Svobodová H; Ceska R Physiol Res; 2008; 57(5):777-784. PubMed ID: 18198982 [TBL] [Abstract][Full Text] [Related]
80. Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication. Mölgaard J; Klausen IC; Lassvik C; Faergeman O; Gerdes LU; Olsson AG Arterioscler Thromb; 1992 Aug; 12(8):895-901. PubMed ID: 1637787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]